Showing 5401-5410 of 6036 results for "".
- Novartis, Mylan and Teva to Supply Tens of Millions of Chloroquine Tablets to Fight COVID-19https://modernod.com/news/novartis-mylan-and-teva-to-supply-tens-of-millions-of-chloroquine-tablets-to-fight-covid-19/2477430/As efforts to discover new COVID-19 medicines roll on, President Donald Trump and others this week focused attention on the decades-old malaria drug chloroquine. Bayer got things rolling with an initial donation of the drug, and now Novartis, Mylan and Teva are takin
- New Podcast Addresses COVID-19 Impacthttps://modernod.com/news/new-podcast-addresses-covid-19-impact/2477431/In the latest installment of the Off the Grid podcast, titled “Unprecedented Times,” cohosts Gary Wörtz, MD, and Blake Williamson, MD, MPH, speak with Steven J. Dell, MD, and Tal Raviv, MD, to discuss the novel coronavirus and its impact on their respective states, practices, and dail
- ASRS Releases Guidelines to Help Retina Practices Navigate COVID-19 Pandemichttps://modernod.com/news/asrs-releases-guidelines-to-help-retina-practices-navigate-covid-19-pandemic/2477427/The American Society of Retina Specialists (ASRS) has released detailed guidelines to help retina practices reduce risk and help assure the health and safety of patients and medical personnel during the COVID-19 pandemic. The guidelines define what constitutes an essential visit and provide a mea
- First-Phase Clinical Trials of China’s First Covid-19 Vaccine to Last Nine Monthshttps://modernod.com/news/first-phase-clinical-trials-of-chinas-first-covid-19-vaccine-to-last-nine-months/2477423/Clinical trials of China’s first inoculation for Covid-19 will run until Dec. 31 this year, according to data made public by the Chinese Clinical Trial Registry, as rep
- Keeping Your Vision Safe During a Natural Disasterhttps://modernod.com/news/keeping-your-vision-safe-during-a-natural-disaster/2477424/Parkhurst Nuvision in San Antonio, Texas, posted the following advisory to its patients, which providing tips for managing vision needs in an emergency. When faced with the forces of nature – in particular flooding and contaminated waters – people who rely on contact lenses to see well fa
- Topcon Announces Customer Initiatives to Combat Global COVID-19 Crisishttps://modernod.com/news/topcon-announces-customer-initiatives-to-combat-global-covid-19-crisis/2477421/As the COVID-19 pandemic continues to escalate across the globe, Topcon Healthcare has announced a series of initiatives and programs designed to support its customers during this time of unprecedented challenges. As healthcare providers, eye doctors are required to be in close contact wit
- Trump Touts Drug That FDA Says Isn’t Yet Approved for Virushttps://modernod.com/news/trump-touts-drug-that-fda-says-isnt-yet-approved-for-virus/2477422/The Food and Drug Administration has been told by President Donald Trump to see if it can expand the use of a decades-old malaria drug as an experimental treatment for coronavirus patients, as
- Chinese Official Claims Fujifilm’s Avigan “Clearly Effective” in Treating COVID-19https://modernod.com/news/chinese-official-claims-fujifilms-avigan-clearly-effective-in-treating-covid-19/2477411/Results of clinical studies conducted in China suggest that Fujifilm’s Avigan (favipiravir) may be effective at treating patients with COVID-19. Zhang Xinmin, director of the China National Center for Biotechnology Development under the Ministry of Science and Technology, remarked “it
- Senate Passes Coronavirus Emergency Aid, Sending Plan To Presidenthttps://modernod.com/news/senate-passes-coronavirus-emergency-aid-sending-plan-to-president/2477409/The Senate approved a new round of emergency funding to address the coronavirus pandemic, sending the legislation to President Trump, who is expected to sign it soon, according to an NPR
- Quidel Receives Emergency Use Authorization for Molecular COVID-19 Diagnostic Assayhttps://modernod.com/news/quidel-receives-emergency-use-authorization-for-molecular-covid-19-diagnostic-assay/2477407/Quidel, a provider of rapid diagnostic testing solutions, announced that the company has received Emergency Use Authorization (EUA) from the FDA to market its Lyra SARS-CoV-2 Assay, a real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal or